Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,366 | -859 | 4,449 | 5,524 | 5,681 |
| Depreciation Amortization | 1 | N/A | 3 | 2 | 1 |
| Accounts receivable | 16 | 15 | 766 | 784 | 581 |
| Other Working Capital | 692 | 447 | 3,113 | 2,999 | 3,240 |
| Other Operating Activity | 12,288 | 272 | -8,330 | -8,834 | -8,112 |
| Operating Cash Flow | $-369 | $-125 | $1 | $475 | $1,391 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | -1 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-2 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 29 | 29 | 11 |
| Financing Cash Flow | $N/A | $N/A | $29 | $29 | $11 |
| Beginning Cash Position | 424 | 424 | 396 | 396 | 396 |
| End Cash Position | 55 | 299 | 424 | 899 | 1,798 |
| Net Cash Flow | $-369 | $-125 | $28 | $503 | $1,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -369 | -125 | 1 | 475 | 1,391 |
| Capital Expenditure | N/A | N/A | -2 | -1 | N/A |
| Free Cash Flow | -369 | -125 | -1 | 474 | 1,391 |